Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POSACONAZOLE Cause Dermatitis exfoliative generalised? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dermatitis exfoliative generalised have been filed in association with POSACONAZOLE (POSACONAZOLE). This represents 0.1% of all adverse event reports for POSACONAZOLE.

7
Reports of Dermatitis exfoliative generalised with POSACONAZOLE
0.1%
of all POSACONAZOLE reports
1
Deaths
7
Hospitalizations

How Dangerous Is Dermatitis exfoliative generalised From POSACONAZOLE?

Of the 7 reports, 1 (14.3%) resulted in death, 7 (100.0%) required hospitalization.

Is Dermatitis exfoliative generalised Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POSACONAZOLE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does POSACONAZOLE Cause?

Drug ineffective (785) Product use in unapproved indication (661) Off label use (430) Drug interaction (383) Death (369) Condition aggravated (214) Pyrexia (185) Neutropenia (181) Product use issue (181) Febrile neutropenia (178)

What Other Drugs Cause Dermatitis exfoliative generalised?

ALLOPURINOL (192) DUPILUMAB (162) METHOTREXATE (151) SULFAMETHOXAZOLE\TRIMETHOPRIM (140) AMOXICILLIN (122) ADALIMUMAB (113) PANTOPRAZOLE (105) SECUKINUMAB (96) VANCOMYCIN (92) AMLODIPINE (91)

Which POSACONAZOLE Alternatives Have Lower Dermatitis exfoliative generalised Risk?

POSACONAZOLE vs POTASSIUM POSACONAZOLE vs POTASSIUM, DIBASIC POSACONAZOLE vs POTASSIUM IODIDE POSACONAZOLE vs POTASSIUM, MONOBASIC POSACONAZOLE vs POTASSIUM\SODIUM FLUORIDE

Related Pages

POSACONAZOLE Full Profile All Dermatitis exfoliative generalised Reports All Drugs Causing Dermatitis exfoliative generalised POSACONAZOLE Demographics